For patients with Barrett’s esophagus, levels of leptin, high-molecular-weight adiponectin, and insulin resistance correlate with esophageal adenocarcinoma risk, according to a study published in the August issue of Clinical Gastroenterology and Hepatology.
http://www.doctorslounge.com/index.php/news/pb/39947
Obesity Markers Linked to Cancer Risk in Barrett’s Esophagus